Eugene

[email protected]

LATEST

Recipharm To Acquire Shares in Injectables Company for $44 Million
By

By
Recipharm, a Jordbro, Sweden-based contract development and manufacturing organization, has agreed to acquire the remaining 26% shares of Nitin Lifesciences, an Indian sterile injectables contract manufacturing organization, making it wholly…

FDA Commissioner Issues Update on Drug Shortages in Puerto Rico
By

By
The US Food and Drug Administration (FDA) Commissioner Scott Gottlieb has issued an update on the agency’s effort to support manufacturing in Puerto Rico following Hurricanes Irma and Maria, particularly…

FDA Issues Draft Guidance on Good ANDA Submission Practices
By

By
The US Food and Drug Administration (FDA) has announced additional steps to encourage generic-drug competition as part of its continued implementation of the Drug Competition Action Plan, which the agency…

Allergan Announces Restructuring; Plans Job Cuts
By

By
Allergan has announced restructuring, which includes staff reductions of 1,000 employees in commercial and other functions, the elimination of 400 open positions, and other cost-cutting actions. The company made the…

Impax to Sell Taiwanese Manufacturing Facility
By

By
Impax Laboratories, a Hayward, California-based specialty pharmaceutical company focused on controlled-release and specialty generics, has agreed to sell its manufacturing facility in Taiwan (Impax Taiwan) to Bora Pharmaceuticals, a Taipei,…

Mallinckrodt To Acquire Sucampo in $1.2-Billion in Rare Disease Deal
By

By
Mallincrodkt, a specialty pharmaceutical company, has agreed to acquire Sucampo Pharmaceuticals, a Bethesda, Maryland-headquartered biopharmaceutical company, for $1.2 billion, which includes Sucampo’s commercial and development assets. Sucampo’s product in the…

Roche To Acquire Biopharm Company Ignyta for $1.7 Billion
By

By
Roche and Ignyta, a San Diego, California-based biopharmaceutical company, have signed a merger agreement under which Roche will acquire Ignyta for $27.00 per share or approximately $1.7 billion. Ignyta is…

AstraZeneca, Teva, and Sanofi Lead Pipeline News
By

By
A roundup of the latest market developments from the pipelines of the pharmaceutical majors, featuring news from AstraZeneca, Teva, Sanofi, and Bayer. Editor’s Note: This article is updated on a…

Pfizer and Spark Therapeutics Lead Drug Approval News
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Pfizer and Spark Therapeutics. Editor’s Note: This article is updated on a continuous basis for…

Marken Expands in India
By

By
Marken, a Research Triangle Park, North Carolina-based provider of logistic and supply-chain services for clinical trial materials, plans to open a new branch in Ahmedabad, India and expand into larger…